Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Temesgen

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Expert Opinion on Pharmacotherapy|October 5, 2001
Current status of antiretroviral therapiesZ Temesgen
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|August 18, 2005
[Bone and joint involvement in human immunodeficiency virus infection]Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|April 26, 2013
Cobicistat, a pharmacoenhancer for HIV treatmentsZ Temesgen
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 7, 1999
Overview of HIV infectionZ Temesgen
Drugs of Today (Barcelona, Spain : 1998)|December 18, 2012
Cobicistat-boosted elvitegravir-based fixed-dose combination antiretroviral therapy for HIV infectionZ Temesgen
Drugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infectionR Talwani, Z Temesgen
Mayo Clinic Proceedings|December 11, 1999
AntiretroviralsZ Temesgen, A J Wright
Mayo Clinic Proceedings|September 19, 1997
Recent advances in the management of human immunodeficiency virus infectionZ Temesgen, A J Wright
Expert Opinion on Pharmacotherapy|May 5, 2001
Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery diseaseS E Girard, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|June 23, 2015
Daclatasvir for the treatment of chronic hepatitis C virus infectionZ Temesgen, S A Rizza
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Expert Opinion on Pharmacotherapy|October 5, 2001
Current status of antiretroviral therapiesZ Temesgen
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|August 18, 2005
[Bone and joint involvement in human immunodeficiency virus infection]Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|April 26, 2013
Cobicistat, a pharmacoenhancer for HIV treatmentsZ Temesgen
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 7, 1999
Overview of HIV infectionZ Temesgen
Drugs of Today (Barcelona, Spain : 1998)|December 18, 2012
Cobicistat-boosted elvitegravir-based fixed-dose combination antiretroviral therapy for HIV infectionZ Temesgen
Drugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infectionR Talwani, Z Temesgen
Mayo Clinic Proceedings|December 11, 1999
AntiretroviralsZ Temesgen, A J Wright
Mayo Clinic Proceedings|September 19, 1997
Recent advances in the management of human immunodeficiency virus infectionZ Temesgen, A J Wright
Expert Opinion on Pharmacotherapy|May 5, 2001
Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery diseaseS E Girard, Z Temesgen
Drugs of Today (Barcelona, Spain : 1998)|June 23, 2015
Daclatasvir for the treatment of chronic hepatitis C virus infectionZ Temesgen, S A Rizza
Pageof 4